147
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk

, , , &
Pages 9-19 | Published online: 18 Dec 2018

References

  • World Health Organization [homepage on the Internet]Global Health Observatory (GHO) data Available from: http://www.who.int/gho/ncd/mortality_morbidity/en/Accessed May 21, 2018
  • CollinsRReithCEmbersonJInterpretation of the evidence for the efficacy and safety of statin therapyLancet2016388100592532256127616593
  • BaigentCKeechAKearneyPMCholesterol Treatment Trialists’ (CTT) CollaboratorsEfficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statinsLancet200536694931267127816214597
  • CatapanoALGrahamIdeBacker GESC Scientific Document Group2016 ESC/EAS Guidelines for the Management of DyslipidaemiasEur Heart J201637392999305827567407
  • ChiangCEFerrièresJGotchevaNNSuboptimal Control of Lipid Levels: Results from 29 Countries Participating in the Centralized Pan-Regional Surveys on the Undertreatment of Hypercholesterolaemia (CEPHEUS)J Atheroscler Thromb201623556758726632163
  • GittAKLautschDFerrieresJLow-density lipoprotein cholesterol in a global cohort of 57,885 statin-treated patientsAtherosclerosis201625520020927667299
  • KotsevaKWoodDDe BacquerDEUROASPIRE InvestigatorsEUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countriesEur J Prev Cardiol201623663664825687109
  • OsterbergLBlaschkeTAdherence to medicationN Engl J Med2005353548749716079372
  • EganBMLiJQanungoSWolfmanTEBlood pressure and cholesterol control in hypertensive hypercholesterolemic patients: national health and nutrition examination surveys 1988–2010Circulation20131281294123817481
  • EwenSMeyerMRCremersBBlood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysisClin Res Cardiol2015104121097110526306594
  • SchulzMKruegerKSchuesselKMedication adherence and persistence according to different antihypertensive drug classes: A retrospective cohort study of 255,500 patientsInt J Cardiol201622066867627393848
  • KurlanskyPHerbertMPrinceSMackMCoronary Artery Bypass Graft Versus Percutaneous Coronary Intervention: Meds Matter: Impact of Adherence to Medical Therapy on Comparative OutcomesCirculation2016134171238124627777293
  • DaskalopoulouSSDelaneyJAFilionKBBrophyJMMayoNESuissaSDiscontinuation of statin therapy following an acute myocardial infarction: a population-based studyEur Heart J200829172083209118664465
  • De VeraMABholeVBurnsLCLacailleDImpact of statin adherence on cardiovascular disease and mortality outcomes: a systematic reviewBr J Clin Pharmacol201478468469825364801
  • ChiMDVansomphoneSSLiuILAdherence to statins and LDL-cholesterol goal attainmentAm J Manag Care2014204e105e11224884955
  • CorraoGParodiANicotraFBetter compliance to antihypertensive medications reduces cardiovascular riskJ Hypertens201129361061821157368
  • MazzagliaGAmbrosioniEAlacquaMAdherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patientsCirculation2009120161598160519805653
  • ChowdhuryRKhanHHeydonEAdherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequencesEur Heart J201334382940294823907142
  • BöhmMSchumacherHLaufsUEffects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular diseaseAm Heart J20131662306.e1314.e123895814
  • ShepsDSSheffieldDDepression, anxiety, and the cardiovascular system: the cardiologist’s perspectiveJ Clin Psychiatry200162Suppl 8126 discussion 17–8
  • KhawajaISWestermeyerJJGajwaniPFeinsteinREDepression and coronary artery disease: the association, mechanisms, and therapeutic implicationsPsychiatry (Edgmont)2009613851
  • DiMatteoMRLepperHSCroghanTWDepression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherenceArch Intern Med2000160142101210710904452
  • ManciaGFagardRNarkiewiczK2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)Eur Heart J201334282159221923771844
  • MoriskyDEAngAKrousel-WoodMWardHJPredictive validity of a medication adherence measure in an outpatient settingJ Clin Hypertens (Greenwich)200810534835418453793
  • GuptaPPatelPŠtrauchBBiochemical Screening for Nonadherence Is Associated With Blood Pressure Reduction and Improvement in AdherenceHypertension20177051042104828847892
  • LaufsUKarmannBPittrowDAtorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular riskClin Res Cardiol2016105978379027120330
  • FoxKMTaiMHKostevKHatzMQianYLaufsUTreatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statinsClin Res Cardiol2018107538038829273856
  • JonesPHNairRThakkerKMPrevalence of dyslipidemia and lipid goal attainment in statin-treated subjects from 3 data sources: a retrospective analysisJ Am Heart Assoc201216e00180023316314
  • GittAKLautschDDe FerrariGHorackMBrudiPFerriéresJConsequent use of available oral lipid Lowering agents would bring the majority of high-risk patients with coronary heart disease to recommended targets: an estimate based on the DYSIS II StudyClin Res Cardiol2018107Suppl 1
  • NeuhauserHKAdlerCRosarioASDiederichsCEllertUHypertension prevalence, awareness, treatment and control in Germany 1998 and 2008–11J Hum Hypertens201529424725325273858
  • JoffresMFalaschettiEGillespieCHypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional studyBMJ Open201338e003423
  • MachFRayKKWiklundOEuropean Atherosclerosis Society Consensus PanelAdverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataractEur Heart J201839272526253929718253
  • SpenceJDDresserGKOvercoming challenges with statin therapyJ Am Heart Assoc201651e00249726819251
  • ZhangHPlutzkyJShubinaMTurchinAContinued Statin Prescriptions After Adverse Reactions and Patient Outcomes: A Cohort StudyAnn Intern Med2017167422122728738423
  • WheltonPKCareyRMAronowWS2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice GuidelinesJ Am Coll Cardiol20187119e127e24829146535
  • WilliamsBManciaGSpieringWESC Scientific Document Group2018 ESC/ESH Guidelines for the management of arterial hypertensionEur Heart J201839333021310430165516
  • EttehadDEmdinCAKiranABlood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysisLancet20163871002295796726724178
  • JefferyRANavarroTWilczynskiNLAdherence measurement and patient recruitment methods are poor in intervention trials to improve patient adherenceJ Clin Epidemiol201467101076108225087180
  • MorrisABLiJKroenkeKBruner-EnglandTEYoungJMMurrayMDFactors associated with drug adherence and blood pressure control in patients with hypertensionPharmacotherapy200626448349216553506
  • LehmannAAslaniPAhmedRAssessing medication adherence: options to considerInt J Clin Pharm2014361556924166659
  • HawksheadJKrousel-WoodMATechniques for Measuring Medication Adherence in Hypertensive Patients in Outpatient SettingsDis Manag Health Outcomes2007152109118
  • KruegerKBotermannLSchorrSGGriese-MammenNLaufsUSchulzMAge-related medication adherence in patients with chronic heart failure: A systematic literature reviewInt J Cardiol201518472873525795085
  • BöhmMLloydSMFordINon-adherence to ivabradine and placebo and outcomes in chronic heart failure: an analysis from SHIFTEur J Heart Fail201618667268326952245
  • LaufsURettig-EwenVBöhmMStrategies to improve drug adherenceEur Heart J201132326426820729544
  • BerminghamMHaydenJDawkinsIProspective analysis of LDL-C goal achievement and self-reported medication adherence among statin users in primary careClin Ther20113391180118921840055
  • CastellanoJMSanzGPeñalvoJLA polypill strategy to improve adherence: results from the FOCUS projectJ Am Coll Cardiol201464202071208225193393
  • Gwadry-SridharFHManiasELalLImpact of interventions on medication adherence and blood pressure control in patients with essential hypertension: a systematic review by the ISPOR medication adherence and persistence special interest groupValue Health201316586387123947982
  • GuptaAKArshadSPoulterNRCompliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysisHypertension201055239940720026768
  • Krousel-WoodMJoyceCHoltEPredictors of decline in medication adherence: results from the cohort study of medication adherence among older adultsHypertension201158580481021968751
  • BauerLKCaroMABeachSREffects of depression and anxiety improvement on adherence to medication and health behaviors in recently hospitalized cardiac patientsAm J Cardiol201210991266127122325974